ARCHIVES

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

NCI to Host SBIR Investor Forum

November 7, 2014

NCI Unconventional Innovations Program releases Broad Agency Announcement.

October 24, 2003

Top 42 CCOPs (According To Priority Scores) Identified; Present Budget Would Draw Payline At 230

April 3, 1987

NCI, IARC Sponsors Workshop On EBV

February 14, 1975

In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS

January 12, 1979